DNLI Operating Cash Flow (Statement)
Denali Therapeutics Inc · Operating Cash Flow (Statement)
DNLI Operating Cash Flow (Statement)
Latest reported-$434.04Mperiod ending
DNLI TTM Cash from Operations (-$72.36M → -$434.04M)
TTM operating cash flow (statement)
High-resolution chart · PNG
DNLI operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -434,040,000 | |
| -412,336,000 | |
| -412,600,000 | |
| -397,777,000 | |
| -349,620,000 | |
| -365,542,000 | |
| -347,694,000 | |
| -362,636,000 | |
| -390,860,000 | |
| -412,809,000 | |
| -357,991,000 | |
| -331,997,000 | |
| -301,680,000 | |
| -231,409,000 | |
| -244,716,000 | |
| -237,547,000 | |
| -221,935,000 | |
| -233,258,000 | |
| -211,389,000 | |
| 368,019,999 | |
| 409,539,999 | |
| 420,403,999 | |
| 416,151,999 | |
| -145,406,000 | |
| -175,927,000 | |
| -175,745,000 | |
| -151,576,000 | |
| -10,748,000 | |
| -15,135,000 | |
| -13,784,000 | |
| 50,116,000 | |
| -61,405,000 | |
| -48,504,000 | |
| -24,249,000 | |
| -76,635,000 | |
| -76,665,000 | |
| -76,031,000 | |
| -74,815,000 | |
| -72,359,000 |